抗精神病药物在自闭症治疗中的应用
Antipsychotics in the treatment of autism.
作者信息
Posey David J, Stigler Kimberly A, Erickson Craig A, McDougle Christopher J
机构信息
Christian Sarkine Autism Treatment Center, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
出版信息
J Clin Invest. 2008 Jan;118(1):6-14. doi: 10.1172/JCI32483.
Abstract
Atypical antipsychotics have become indispensable in the treatment of a variety of symptoms in autism. They are frequently used to treat irritability and associated behaviors including aggression and self injury. They may also be efficacious for hyperactivity and stereotyped behavior. This review presents the rationale for the use of this drug class in autism and reviews the most important studies published on this topic to date. Significant adverse effects, including weight gain and the possibility of tardive dyskinesia, are reviewed. Future research directions are discussed.
摘要
非典型抗精神病药物在自闭症多种症状的治疗中已变得不可或缺。它们常被用于治疗易激惹及相关行为，包括攻击行为和自我伤害行为。它们对多动和刻板行为可能也有效。本综述阐述了在自闭症中使用这类药物的基本原理，并回顾了迄今为止关于该主题发表的最重要研究。还综述了包括体重增加和迟发性运动障碍可能性在内的显著不良反应。并讨论了未来的研究方向。
相似文献
1
Antipsychotics in the treatment of autism.抗精神病药物在自闭症治疗中的应用
J Clin Invest. 2008 Jan;118(1):6-14. doi: 10.1172/JCI32483.
2
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.阿立哌唑治疗孤独症谱系障碍儿童烦躁症状的安全性和耐受性：一项 52 周、开放标签、多中心研究。
J Clin Psychiatry. 2011 Sep;72(9):1270-6. doi: 10.4088/JCP.09m05933. Epub 2011 Jul 26.
3
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
4
Aripiprazole for the treatment of irritability associated with autism.阿立哌唑治疗孤独症相关的易激惹。
Expert Opin Pharmacother. 2011 Mar;12(4):635-40. doi: 10.1517/14656566.2011.557661. Epub 2011 Feb 6.
5
Pharmacotherapy of irritability in pervasive developmental disorders.广泛性发育障碍中易激惹症状的药物治疗
Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002.
6
A systematic review of the use of atypical antipsychotics in autism.对非典型抗精神病药物在自闭症治疗中的应用的系统评价。
J Psychopharmacol. 2002 Mar;16(1):93-101. doi: 10.1177/026988110201600113.
7
The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.抗精神病药物在自闭症儿童和青少年行为症状管理中的作用。
Drugs. 2009;69(5):535-48. doi: 10.2165/00003495-200969050-00003.
8
[Topiramate reduces irritability and self-injuries in autistic children].托吡酯可减轻自闭症儿童的易怒情绪和自我伤害行为
Braz J Psychiatry. 2005 Dec;27(4):345-6. doi: 10.1590/s1516-44462005000400021. Epub 2005 Dec 12.
9
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.自闭症谱系障碍中药物难治性攻击行为、自伤行为和严重发脾气：一项图表回顾研究。
Autism. 2015 Jan;19(1):102-6. doi: 10.1177/1362361314524641. Epub 2014 Feb 26.
10
Tardive dyskinesia in an autistic patient treated with risperidone.一名接受利培酮治疗的自闭症患者出现迟发性运动障碍。
Am J Psychiatry. 2004 Apr;161(4):757-8. doi: 10.1176/appi.ajp.161.4.757-a.
引用本文的文献
1
Antipsychotic Drugs and Dysregulated Glucose Homeostasis: A Systematic Review and Meta-Analysis.抗精神病药物与葡萄糖稳态失调：一项系统评价与荟萃分析
JAMA Psychiatry. 2025 Aug 27. doi: 10.1001/jamapsychiatry.2025.2240.
2
Antipsychotic management in general practice: serial cross-sectional study (2011-2020).全科医疗中的抗精神病药物管理：系列横断面研究（2011 - 2020年）
Br J Gen Pract. 2024 Dec 26;75(750):e68-e79. doi: 10.3399/BJGP.2024.0367. Print 2025 Jan.
3
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism.大麻二酚在特发性自闭症的BTBR小鼠模型中是一种行为调节剂。
Front Neurosci. 2024 May 9;18:1359810. doi: 10.3389/fnins.2024.1359810. eCollection 2024.
4
Ethical and Legal Aspects in the Treatment of Autism Spectrum Disorder.自闭症谱系障碍治疗中的伦理与法律问题
Focus (Am Psychiatr Publ). 2024 Apr;22(2):184-188. doi: 10.1176/appi.focus.20230032. Epub 2024 Apr 10.
5
Examining the Use of Oral Aripiprazole in Patients With Autism Spectrum Disorder: A Study of Retrospective Chart Review at a University Medical Center.评估口服阿立哌唑在自闭症谱系障碍患者中的应用：一项大学医学中心回顾性病历审查研究。
J Korean Acad Child Adolesc Psychiatry. 2024 Apr 1;35(2):136-142. doi: 10.5765/jkacap.230057.
6
Management of antipsychotics in primary care: Insights from healthcare professionals and policy makers in the United Kingdom.基层医疗中的抗精神病药物管理：来自英国医疗保健专业人员和政策制定者的见解。
PLoS One. 2024 Mar 1;19(3):e0294974. doi: 10.1371/journal.pone.0294974. eCollection 2024.
7
The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.候选药代动力学和药效动力学基因的多态性及其对沙特自闭症儿童利培酮维持治疗效果的遗传药理学影响。
Eur J Clin Pharmacol. 2024 Jun;80(6):869-890. doi: 10.1007/s00228-024-03658-w. Epub 2024 Feb 29.
8
The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation.澳大利亚西部孤独症个体（21 岁及以下）使用精神类药物：初步调查。
Autism. 2024 Aug;28(8):2002-2013. doi: 10.1177/13623613231226099. Epub 2024 Feb 22.
9
Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry.神经精神疾病：弥合神经病学与精神病学之间的差距
Cureus. 2024 Jan 4;16(1):e51655. doi: 10.7759/cureus.51655. eCollection 2024 Jan.
10
Quetiapine and Valproic Acid-induced Central Hypothyroidism in a Patient with Autism Spectrum Disorder and Intractable Epilepsy: A Case Report.喹硫平与丙戊酸致自闭症谱系障碍及难治性癫痫患者中枢性甲状腺功能减退症 1 例报告
Endocr Metab Immune Disord Drug Targets. 2024;24(13):1581-1585. doi: 10.2174/0118715303261457231120114231.
本文引用的文献
1
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.自闭症谱系障碍的患病率——自闭症与发育障碍监测网络，美国14个监测点，2002年
MMWR Surveill Summ. 2007 Feb 9;56(1):12-28.
2
Risperidone and cognitive function in children with disruptive behavior disorders.利培酮与破坏性行为障碍儿童的认知功能
Biol Psychiatry. 2007 Aug 1;62(3):226-34. doi: 10.1016/j.biopsych.2006.09.036. Epub 2007 Jan 8.
3
Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.利培酮用于患有自闭症谱系障碍的学龄前儿童：安全性和有效性的调查。
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):575-87. doi: 10.1089/cap.2006.16.575.
4
Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.利培酮对广泛性发育障碍儿童的神经心理学影响：一项双盲撤药研究。
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):561-73. doi: 10.1089/cap.2006.16.561.
5
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.奥氮平用于儿童/青少年广泛性发育障碍的双盲安慰剂对照试验性研究。
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):541-8. doi: 10.1089/cap.2006.16.541.
6
Risperidone in children with autism: randomized, placebo-controlled, double-blind study.利培酮治疗儿童自闭症：随机、安慰剂对照、双盲研究。
J Child Neurol. 2006 Jun;21(6):450-5. doi: 10.1177/08830738060210060801.
7
Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification.广泛性发育障碍青少年的行为和情绪问题：相对患病率、个体特征的影响及实证分类
J Autism Dev Disord. 2006 Nov;36(8):1101-14. doi: 10.1007/s10803-006-0147-5.
8
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.短期和长期使用利培酮治疗对自闭症儿童催乳素水平的影响。
Biol Psychiatry. 2007 Feb 15;61(4):545-50. doi: 10.1016/j.biopsych.2006.02.032. Epub 2006 May 30.
9
Neurochemistry in the pathophysiology of autism.自闭症病理生理学中的神经化学
J Clin Psychiatry. 2005;66 Suppl 10:9-18.
10
Acute and long-term safety and tolerability of risperidone in children with autism.利培酮在自闭症儿童中的急性和长期安全性及耐受性
J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84. doi: 10.1089/cap.2005.15.869.
Zotero 插件